The pandemic has transformed the way we manage our lives. Over the past 18 months, we’ve learned to do things differently and not do some things at all, like go to the office! Our ability to adapt and virtually communicate is due largely to the significant enabler that is technology.
For those with a chronic disease to manage, the ease of access to telemedicine has offered other ways in which we can access healthcare providers and healthcare systems. While we cannot address everything online, we can go a long way towards protecting those most vulnerable, and importantly, we have learned how we can continue to provide a level of life-changing or lifesaving healthcare outside of the normal clinical setting.
For years before the pandemic an increasing number of home births occurred, telehealth solutions were available and growing which enabled more expedient access to a GP. Wearable solutions monitoring vital signs and blood sugar levels are now omnipresent and even clinical interventions at home by hospital-trained medical and nursing staff have been commonplace for years. Through necessity, we have experienced an evolution in healthcare service and it appears unlikely we will return to old habits.
In 2009 the Cochrane review in Britain demonstrated a 38% reduction in mortality rates for patients treated at home compared to in hospital and an estimated 20% reduction in costs, both achieved without significant technological support. Additional evidence suggests telemedicine improves patient outcomes providing a better patient experience. Telemedicine improves patient recovery and adherence to therapies while increasing their ability to get on with their daily lives. Innovations including digital tools and mobile applications that deliver medicines and treatments include patient tracking and monitoring systems, enable self-care and early warning of significant changes to disease progression.
Monitoring patient safety and drug safety remotely provides both patients and their doctors with the equivalent security and support that point of care services provide without the associated costs and inconveniences. Digitally enabled services provide a safe and cost-effective way of keeping in touch. Patients can be monitored remotely using a mobile application that reports key measures such as symptomatic improvements or exacerbations, adverse drug reactions, and wellbeing. Smartphones today allow for two-way communication between caregiver and patient creating a seamless infrastructure of care, information, and support without expensive, specialized equipment.
Digitally enabled services provide the wrap-around care that most patients with long-term conditions and lifelong rare diseases need, allowing them the freedom to get on with their lives. For those investing in such technologies, a recent BDO survey suggests 74% of companies realise an increase in profitability within 12 months.
RareiTi Care is a fully customizable digital patient care program (platform) designed to achieve better outcomes for rare disease patients, drug developers and healthcare providers. Call us today for a free demo and find out why RareiTiCare could be the solution you’ve been looking for.